Figure 1â€” Enrollment, patient disposition, and baseline characteristics. Of the 303 patients originally randomized to the study, 258 entered the subsequent 22-week assessment period. Fifteen patients withdrew during the 22-week assessment period, resulting in an evaluable population of n/H11005 241 ( n/H11005120 QW only; n/H11005121 BID3QW). Demographics of the ITT population are available in Drucker et al. (17) and represent the information at the original baseline. MET, metformin; SFU, sulfonylurea; TZD, thiazolidinedione.Buse and Associates care.diabetesjournals.org D IABETES CARE,VOLUME 33, NUMBER 6, J UNE2010 1257Downloaded from http://diabetesjournals.org/care/article-pdf/33/6/1255/605969/zdc0061000 255.pdf by guest on 17 January 2024